Ajooni Biotech [AJOONI] vs Nakoda Group of [NGIL] Detailed Stock Comparison

Ajooni Biotech

NSE
Loading...

Nakoda Group of

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Ajooni Biotech wins in 8 metrics, Nakoda Group of wins in 10 metrics, with 0 ties. Nakoda Group of appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricAjooni BiotechNakoda Group ofBetter
P/E Ratio (TTM)26.10635.00Ajooni Biotech
Price-to-Book Ratio2.301.88Nakoda Group of
Debt-to-Equity Ratio6.0444.43Ajooni Biotech
PEG RatioN/A-5.27N/A
EV/EBITDA55.79-63.84Nakoda Group of
Profit Margin (TTM)3.06%-6.57%Ajooni Biotech
Operating Margin (TTM)1.49%7.80%Nakoda Group of
EBITDA Margin (TTM)1.49%7.80%Nakoda Group of
Return on Equity4.23%-13.05%Ajooni Biotech
Return on Assets (TTM)1.50%-8.69%Ajooni Biotech
Free Cash Flow (TTM)$-197.69M$-40.54MNakoda Group of
1-Year Return-45.17%-6.29%Nakoda Group of
Price-to-Sales Ratio (TTM)0.431.03Ajooni Biotech
Enterprise Value$1.94B$664.42MAjooni Biotech
EV/Revenue Ratio1.611.49Nakoda Group of
Gross Profit Margin (TTM)22.46%26.37%Nakoda Group of
Revenue per Share (TTM)$5$28Nakoda Group of
Earnings per Share (Diluted)$0.20$-1.98Ajooni Biotech
Beta (Stock Volatility)0.33-0.18Nakoda Group of
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Ajooni Biotech vs Nakoda Group of Stock Performance Analysis

Loading Price Chart...

Ajooni Biotech
Nakoda Group of
Ajooni Biotech Stock Overview | Nakoda Group of Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Ajooni Biotech-1.34%-0.57%0.00%-7.61%-26.27%-35.95%
Nakoda Group of2.95%14.60%29.16%14.94%-4.23%-20.63%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Ajooni Biotech-45.17%-86.97%-82.15%-90.25%-90.25%-90.25%
Nakoda Group of-6.29%-75.96%-47.18%-47.18%-47.18%-47.18%

News Based Sentiment: Ajooni Biotech vs Nakoda Group of

Ajooni Biotech

News based Sentiment: NEUTRAL

The announcements primarily concern standard corporate governance procedures – an upcoming AGM with proposals for shareholder approval on related party transactions, investments, and auditor appointments. While significant for corporate operations, these events don't represent a dramatic shift in the company's overall investment story.

View Ajooni Biotech News Sentiment Analysis

Nakoda Group of

News based Sentiment: POSITIVE

September saw Nakoda Group of Industries Ltd. experience significant stock gains on both major exchanges, accompanied by substantial bulk purchases, indicating strong investor confidence. The upcoming AGM provides a key opportunity for investors to assess the company's future direction, making this a noteworthy month for the company.

View Nakoda Group of News Sentiment Analysis

Performance & Financial Health Analysis: Ajooni Biotech vs Nakoda Group of

MetricAJOONINGIL
Market Information
Market Cap i₹512.64M₹508.60M
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i805,657662,324
90 Day Avg. Volume i455,238264,835
Last Close₹5.15₹35.89
52 Week Range₹5.01 - ₹9.89₹25.61 - ₹48.00
% from 52W High-47.93%-25.23%
All-Time High₹85.85 (Feb 07, 2022)₹328.00 (Jan 03, 2022)
% from All-Time High-94.00%-89.06%
Growth Metrics
Quarterly Revenue Growth0.22%-0.20%
Quarterly Earnings Growth0.67%-0.20%
Financial Health
Profit Margin (TTM) i0.03%-0.07%
Operating Margin (TTM) i0.01%0.08%
Return on Equity (TTM) i0.04%-0.13%
Debt to Equity (MRQ) i6.0444.43
Cash & Liquidity
Book Value per Share (MRQ)₹2.27₹19.18
Cash per Share (MRQ)₹0.40₹0.25
Operating Cash Flow (TTM) i₹-198,640,000₹-42,295,000
Levered Free Cash Flow (TTM) i₹33.72M₹-36,406,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A₹0.00

Valuation & Enterprise Metrics Analysis: Ajooni Biotech vs Nakoda Group of

MetricAJOONINGIL
Price Ratios
P/E Ratio (TTM) i26.10635.00
Forward P/E iN/AN/A
PEG Ratio iN/A-5.27
Price to Sales (TTM) i0.431.03
Price to Book (MRQ) i2.301.88
Market Capitalization
Market Capitalization i₹512.64M₹508.60M
Enterprise Value i₹1.94B₹664.42M
Enterprise Value Metrics
Enterprise to Revenue i1.611.49
Enterprise to EBITDA i55.79-63.84
Risk & Other Metrics
Beta i0.33-0.18
Book Value per Share (MRQ) i₹2.27₹19.18

Financial Statements Comparison: Ajooni Biotech vs Nakoda Group of

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)AJOONINGIL
Revenue/Sales i₹292.74M₹69.21M
Cost of Goods Sold i₹227.00M₹50.96M
Gross Profit i₹65.75M₹18.25M
Research & Development iN/AN/A
Operating Income (EBIT) i₹6.32M₹5.40M
EBITDA i₹23.50M₹8.35M
Pre-Tax Income i₹19.12M₹2.07M
Income Tax i₹3.68M₹496,000
Net Income (Profit) i₹15.44M₹1.57M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)AJOONINGIL
Cash & Equivalents i₹68.30M₹4.30M
Total Current Assets i₹620.04M₹282.50M
Total Current Liabilities i₹48.21M₹128.63M
Long-Term Debt i₹19.40M₹10.34M
Total Shareholders Equity i₹880.79M₹278.93M
Retained Earnings iN/AN/A
Property, Plant & Equipment i₹109.33M₹129.44M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)AJOONINGIL
Operating Cash Flow iN/A₹14.35M
Capital Expenditures iN/A₹-29.77M
Free Cash Flow iN/A₹-34.26M
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricAJOONINGIL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i805,657662,324
Average Daily Volume (90 Day) i455,238264,835
Shares Outstanding i99.37M17.82M
Float Shares i338.16M9.53M
% Held by Insiders iN/A0.66%
% Held by Institutions iN/A0.00%

Dividend Analysis & Yield Comparison: Ajooni Biotech vs Nakoda Group of

MetricAJOONINGIL
Last 12-Month Dividend iN/A₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A₹0.13
3-Year Avg Dividend Yield iN/A0.23%
3-Year Total Dividends iN/A₹0.40
Ex-Dividend DateN/ASep 22, 2023